[Significance of serum concentrations of pro- and anti-inflammatory cytokines in identification of patients with Crohn's disease].

PubWeight™: 0.78‹?›

🔗 View Article (PMID 20931826)

Published in Pol Merkur Lekarski on September 01, 2010

Authors

Maciej Kohut1, Marek Hartleb, Teresa Hartleb

Author Affiliations

1: Slaski Uniwersytet Medyczny w Katowicach, Katedra i Klinika Gastroenterologii i Hepatologii. kohutm66@wp.pl

Articles by these authors

Serum chemerin and vaspin in non-alcoholic fatty liver disease. Scand J Gastroenterol (2010) 1.69

Kidneys in chronic liver diseases. World J Gastroenterol (2012) 1.10

Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension. World J Gastroenterol (2011) 1.00

Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature. Hepat Mon (2011) 0.97

Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery. Pol J Pathol (2010) 0.87

Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol (2010) 0.85

Composite neuroendocrine and adenomatous carcinoma of the papilla of Vater. World J Gastroenterol (2009) 0.85

Severe dilated cardiomyopathy as a consequence of Ecstasy intake. Cardiovasc Pathol (2007) 0.84

Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int (2013) 0.81

Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. Hepatol Int (2011) 0.79

Haemobilia causing acute pancreatitis after percutaneous liver biopsy. J Hepatol (2004) 0.79

Comment on "Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-beta". J Immunol (2009) 0.77

Serum vaspin may be a good indicator of fibrosis in chronic hepatitis C and is not altered by antiviral therapy. Pol J Pathol (2012) 0.77

Omentin serum concentration and hepatic expression in chronic hepatitis C patients - together or apart? Pol J Pathol (2015) 0.77

In patients with liver cirrhosis, proinflammatory interleukins correlate with health-related quality of life irrespective of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol (2013) 0.77

Treatment of pruritus with Prometheus dialysis and absorption system in a patient with benign recurrent intrahepatic cholestasis. Hepatol Res (2013) 0.76

Critical flicker frequency fails to disclose brain dysfunction in patients with primary biliary cirrhosis. Dig Liver Dis (2010) 0.76

Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China. Clin Drug Investig (2014) 0.76

A composite model including visfatin, tissue polypeptide-specific antigen, hyaluronic acid, and hematological variables for the diagnosis of moderate-to-severe fibrosis in nonalcoholic fatty liver disease: a preliminary study. Pol Arch Med Wewn (2014) 0.75

Age and immunoglobulin G4-associated autoimmune hepatitis. Liver Int (2009) 0.75

A rare cause of chylous ascites. Liver Int (2011) 0.75

[Evaluation of probability of bile duct stone presence by using of non-invasive procedures]. Pol Arch Med Wewn (2003) 0.75

[Inflammatory bowel diseases in pregnancy]. Ginekol Pol (2009) 0.75

Vaspin mRNA levels in the liver of morbidly obese women with nonalcoholic fatty liver disease. Pol J Pathol (2017) 0.75

Autoimmune LKM1 hepatitis presenting in the form of recurrent acute episodes. Am J Gastroenterol (2002) 0.75

[Assessment of prevalence of intrapulmonary arterio-venous shunt in cirrhotic patients qualified to liver transplantation]. Wiad Lek (2009) 0.75

Hepatic arterial dot signs in isolated small duct primary sclerosing cholangitis. J Gastroenterol Hepatol (2004) 0.75

[Autoimmune hepatitis in the sight of contemporary immunology]. Pol Arch Med Wewn (2002) 0.75

Hepatic chemerin mRNA in morbidly obese patients with nonalcoholic fatty liver disease. Pol J Pathol (2017) 0.75

[Serum level of TNF-alpha receptor type II better correlates with severity of Crohn's disease than other cytokines and conventional clinical activity indicators]. Pol Merkur Lekarski (2010) 0.75

Pernicious anemia during peginterferon-alpha2b plus ribavirin therapy for chronic hepatitis C. Eur J Gastroenterol Hepatol (2009) 0.75

[Endoscopic assessment of large bowel and safety of bowel preparation and sedoanalgesia in patients with advanced liver cirrhosis]. Przegl Lek (2011) 0.75

[Alcoholic liver disease]. Wiad Lek (2003) 0.75

Cytophagic hemorrhagic panniculitis and severe steatohepatitis: challenging combination. J Gastroenterol Hepatol (2005) 0.75

[85-years-old patient with paraneoplastic polyneuropathy]. Wiad Lek (2007) 0.75

An unusual cause of hepatic encephalopathy. Pol Arch Med Wewn (2015) 0.75

Left-hemihepatectomy as a method of treatment of locally limited Caroli disease. Pol Przegl Chir (2013) 0.75

Comparison of patency and cost-effectiveness of self-expandable metal and plastic stents used for malignant biliary strictures: a Polish single-center study. Eur J Gastroenterol Hepatol (2016) 0.75

Moyamoya-like vascular pattern of the hepatic portal in primary sclerosing cholangitis associated with portal vein occlusion. Ultraschall Med (2007) 0.75